Eurocine Vaccines AB has published two interviews with CEO Hans Arwidsson in connection with the ongoing preferential issue of units. The interviews, which have partly different content, are in writing and in English and Swedish, respectively.
For interview in English, please see:
Interview with CEO Hans Arwidsson at IPOhub
For interview in Swedish, please see: